CME: Current Trends in Multiple Myeloma: Customizing Treatment Strategies and Optimizing Outcomes

Article Type

Article

Changed

Tue, 05/21/2019 - 12:12

Display Headline

CME: Current Trends in Multiple Myeloma: Customizing Treatment Strategies and Optimizing Outcomes

Click here to read the digital edition of the supplement

This supplement is supported by an educational education grant from Celgene and Janssen Biotech, Inc.

Topics Include:

Advances in diagnosis and prognosis
Management of the newly diagnosed patient
Treatment advances and current management strategies for relapsed/refractory patients
Future treatment directions

About the Author

Thomas R. Chauncey, MD, PhD
Associate Professor of Medicine and Oncology
University of Washington
Associate Member
Fred Hutchinson Cancer Research Center
Director, Marrow Transplant Unit
VA Puget Sound Health Care System
Seattle, WA

Click here to read the digital edition of the supplement

Article PDF

0918fedsupp_mm_cme_v12.pdf

Publications

Federal Practitioner

Topics

Oncology

Sections

CME Supplements

Medical Education Library

Supplements

Article PDF

0918fedsupp_mm_cme_v12.pdf

Article PDF

0918fedsupp_mm_cme_v12.pdf

Click here to read the digital edition of the supplement

This supplement is supported by an educational education grant from Celgene and Janssen Biotech, Inc.

Topics Include:

Advances in diagnosis and prognosis
Management of the newly diagnosed patient
Treatment advances and current management strategies for relapsed/refractory patients
Future treatment directions

About the Author

Thomas R. Chauncey, MD, PhD
Associate Professor of Medicine and Oncology
University of Washington
Associate Member
Fred Hutchinson Cancer Research Center
Director, Marrow Transplant Unit
VA Puget Sound Health Care System
Seattle, WA

Click here to read the digital edition of the supplement

This supplement is supported by an educational education grant from Celgene and Janssen Biotech, Inc.

Topics Include:

Advances in diagnosis and prognosis
Management of the newly diagnosed patient
Treatment advances and current management strategies for relapsed/refractory patients
Future treatment directions

About the Author

Thomas R. Chauncey, MD, PhD
Associate Professor of Medicine and Oncology
University of Washington
Associate Member
Fred Hutchinson Cancer Research Center
Director, Marrow Transplant Unit
VA Puget Sound Health Care System
Seattle, WA